Linearity [Regulatives / Guidelines]

posted by jag009  – NJ, 2022-01-24 16:06 (994 d 22:24 ago) – Posting: # 22752
Views: 3,122

Hi Ohlbe,

❝ Does your drug show linear PK ? If not: does it show more-than-proportional increase (then the highest strength would be more sensitive to show differences in BA) or less-than-proportional increase (lowest strength would be more sensitive, giving you good arguments) ?


Yes its linear PK. I read the FDA guidance about Guidance, for NDA it seeems "possible" as long as one can provide safety and efficacy data.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,258 posts in 4,886 threads, 1,671 registered users;
79 visitors (0 registered, 79 guests [including 10 identified bots]).
Forum time: 15:30 CEST (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5